Philip Eykerman is on the board of Centrient Pharmaceuticals Netherlands BV, Chemicainvest Holding BV and AOC Aliancys AG and EVP-Corporate Strategy, Merger & Acquisitions at Koninklijke DSM NV.

In the past Mr. Eykerman was Partner at McKinsey & Company Inc. Italy.

Mr. Eykerman received a graduate degree from Katholieke Universiteit Leuven and a graduate degree from IFP School.